RLLVF (Relevium Technologies) Total Stockholders Equity: $-0.90 Mil (As of Mar. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Relevium Technologies Total Stockholders Equity?

Relevium Technologies RLLVF -99.98% Total Stockholders Equity is $-0.90 Mil as of Mar. 2022.

Relevium Technologies's Total Stockholders Equity for the quarter that ended in Mar. 2022 was $-0.90 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Relevium Technologies's Book Value per Share for the quarter that ended in Mar. 2022 was $-0.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Relevium Technologies's Debt-to-Equity for the quarter that ended in Mar. 2022 was -1.29.


Relevium Technologies  (OTCPK:RLLVF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Relevium Technologies's Book Value per Share for the quarter that ended in Mar. 2022 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Relevium Technologies's Debt-to-Equity for the quarter that ended in Mar. 2022 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Relevium Technologies Total Stockholders Equity Related Terms


Relevium Technologies Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Relevium Technologies's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Relevium Technologies Total Stockholders Equity Chart

Relevium Technologies Annual Data
Trend Dec12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.75 3.89 3.80 0.04 -4.01

Relevium Technologies Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.57 -4.01 -2.29 -1.58 -0.90
What does a Total Stockholders Equity of $-0.90 Mil mean?
Relevium Technologies (RLLVF) has a Total Stockholders Equity of $-0.90 Mil as of Mar. 2022. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Relevium Technologies and its competitors.
Is Relevium Technologies' Total Stockholders Equity too high?
Relevium Technologies' current Total Stockholders Equity is $-0.90 Mil.
How does Relevium Technologies' Total Stockholders Equity compare to HEWA and SSY?
Relevium Technologies' Total Stockholders Equity of $-0.90 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Healthcare Providers & Services company?
A good Total Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Relevium Technologies and its competitors. Relevium Technologies's current Total Stockholders Equity is $-0.90 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Relevium Technologies stock overvalued right now?
Relevium Technologies (RLLVF) has a current Total Stockholders Equity of $-0.90 Mil. The current Total Stockholders Equity is $-0.90 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Relevium Technologies (RLLVF), the current Total Stockholders Equity is $-0.90 Mil as of Mar. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Relevium Technologies Business Description

Address 1000 Sherbrooke Street West, Suite 2700, Montreal, QC, CAN, H3A 3G4
Relevium Technologies Inc is a Canada based company operates in the health and wellness industry with a primary focus on online distribution. The principal business of the Company is the identification, evaluation, acquisition, and operations of brands and businesses in the health and wellness markets including medical cannabis. Its operating segment includes Consumer Packaged Goods (CPG); Pediatric Biopharma and Corporate. The company generates maximum revenue from Consumer Packaged Goods segment.